Bora Pharmaceuticals Co., Ltd. (TPE:6472)
Taiwan · Delayed Price · Currency is TWD 346.00
+10.00 (2.98%)
May 29, 2026, 1:30 PM CST
Bora Pharmaceuticals Market Cap
Bora Pharmaceuticals has a market cap or net worth of 43.94 billion as of May 29, 2026. Its market cap has decreased by -38.70% in one year.
Market Cap
43.94B
Enterprise Value
58.65B
Revenue
18.54B
Ranking
n/a
PE Ratio
38.65
Stock Price
346.00
Market Cap Chart
Since October 3, 2014, Bora Pharmaceuticals's market cap has increased from 3.16B to 43.94B, an increase of 1,289.62%. That is a compound annual growth rate of 25.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 43.94B | -27.40% |
| Dec 31, 2025 | 60.52B | -22.12% |
| Dec 31, 2024 | 77.71B | 20.27% |
| Dec 29, 2023 | 64.61B | 107.61% |
| Dec 30, 2022 | 31.12B | 150.04% |
| Dec 30, 2021 | 12.45B | 17.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lotus Pharmaceutical | 50.33B |
| Center Laboratories | 27.81B |
| TTY Biopharm Company | 18.20B |
| Synmosa Biopharma | 15.21B |
| ScinoPharm Taiwan | 15.02B |
| YungShin Global Holding | 14.78B |
| Grape King Bio | 14.75B |
| Foresee Pharmaceuticals | 12.30B |